National Association for Proton Therapy (NAPT) is a non-profit organization dedicated to promoting the use of proton therapy as an advanced and effective form of cancer treatment. The NAPT Board of Directors plays a pivotal role in guiding the organization’s mission, vision, and strategic direction. The board is composed of distinguished professionals from various roles within the field of proton therapy, each bringing their expertise, experience, and commitment to advancing proton therapy and supporting cancer patients.
Board of Directors
Executive Committee

Jeffrey Bradley, MD
Professor of Radiation Oncology
University of Penn

Michael Butkus, PhD
Co-Medical Director/Head of Proton Physics
University of Miami

Andrew Chang, MD
Medical Director, Pediatrics
California Protons Cancer Therapy Center

Judy Chatigny
Executive Director
Loma Linda University

Ashish K. Chawla, MD
Chairman Proton Therapy
Inova Schar Cancer Institute

Isabelle Choi, MD, FACRO
Director of Research
New York Proton Center

Eric Cleveland
Administrator
Department of Radiation Oncology
Mayo Clinic Rochester

James Gray, MD
Medical Director
Tennessee Oncology Proton Center

Steven Holan, MBA
Vice President, Operations
Baptist Health South Florida

Darrin Kistler
Senior Director, Radiation Services
The University of Kansas

Randall K McClure
Director of Proton Therapy
Fred Hutch Cancer Center

Mark McDonald, MD
Medical Director
Emory Proton Therapy Center

Tomain Murphy
Vice President, Radiation Oncology and Ancillary Services Operations
Levine Cancer – Atrium Health

Elizabeth Nichols, MD
Associate Professor
Maryland Proton Treatment Center

Stephanie Perkins, MD
Director, S. Lee Kling Proton Therapy Center
Siteman Cancer Center

Helen Shih, MD
Massachusetts General Hospital
Medical Director, MGH Proton Therapy Centers